Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis-Reference-Cited by-同舟云学术

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis

Published:2021-10-01 Issue:10 Volume:78 Page:1197
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Spelman Tim¹,Magyari Melinda²³⁴,Piehl Fredrik¹,Svenningsson Anders⁵,Rasmussen Peter Vestergaard⁶,Kant Matthias⁷⁸,Sellebjerg Finn³⁴,Joensen Hanna²⁴,Hillert Jan¹,Lycke Jan⁹¹⁰

Affiliation:

1. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden

2. The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital–Rigshospitalet, Copenhagen, Denmark

3. Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital–Rigshospitalet, Copenhagen, Denmark

4. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

5. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden

6. Department of Neurology, Aarhus University Hospital, Aarhus, Denmark

7. Multiple Sclerosis Clinic Southern Denmark, Department of Brain and Nerve Diseases, University of Southern Denmark, Odense, Denmark

8. Department of Brain & Nerve Diseases, Hospital of Southern Jutland, Odense, Denmark

9. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden

10. Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2783261/jamaneurology_spelman_2021_oi_210048_1633018736.34183.pdf

Reference44 articles.

1. A novel tool to improve shared decision making and adherence in multiple sclerosis: development and preliminary testing.;Col;MDM Policy Pract,2019

2. Evolving concepts in the treatment of relapsing multiple sclerosis.;Comi;Lancet,2017

3. Personalised medicine for multiple sclerosis care.;Gafson;Mult Scler,2017

4. Advances in and algorithms for the treatment of relapsing-remitting multiple sclerosis.;Ingwersen;Neurotherapeutics,2016

5. Treatment decisions in multiple sclerosis—insights from real-world observational studies.;Trojano;Nat Rev Neurol,2017

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines;Multiple Sclerosis and Related Disorders;2024-03

2. Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden;Multiple Sclerosis Journal;2024-01-19

3. Documento de consenso de la Sociedad Española de Neurología sobre el tratamiento de la esclerosis múltiple y manejo holístico del paciente 2023;Neurología;2024-01

4. Disease-modifying therapies;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024

5. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023;Neurología (English Edition);2024-01